Equity Considerations in COVID‐19 Vaccination Studies of Individuals With Autoimmune Inflammatory Rheumatic Diseases-Reference-Cited by-同舟云学术

Equity Considerations in COVID‐19 Vaccination Studies of Individuals With Autoimmune Inflammatory Rheumatic Diseases

Published:2022-12-07 Issue:5 Volume:75 Page:967-974
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care & Research

Author:

Wang Harry¹^ORCID,Dewidar Omar²,Whittle Samuel L.³^ORCID,Ghogomu Elizabeth²,Hazlewood Glen⁴,Leder Karin⁵,Mbuagbaw Lawrence⁶,Pardo Pardo Jordi⁷,Robinson Philip C.⁸^ORCID,Buchbinder Rachelle⁵^ORCID,Welch Vivian²

Affiliation:

1. University of Ottawa and Bruyère Research Institute Ottawa Ontario Canada

2. Bruyère Research Institute Ottawa Ontario Canada

3. The Queen Elizabeth Hospital, Adelaide, South Australia, Australia, and Monash University Melbourne Victoria Australia

4. University of Calgary Calgary Alberta Canada

5. Monash University Melbourne Victoria Australia

6. McMaster University and St Joseph's Healthcare Hamilton Ontario Canada

7. University of Ottawa Ottawa Ontario Canada

8. University of Queensland School of Medicine and Royal Brisbane and Women's Hospital Brisbane Queensland Australia

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr.25034

Reference45 articles.

1. COVID‐19 Outcomes in Patients With Systemic Autoimmune Rheumatic Diseases Compared to the General Population: A US Multicenter, Comparative Cohort Study

2. Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study

3. Risk of Severe COVID-19 Infection in Patients With Inflammatory Rheumatic Diseases

4. Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021

5. Association of Race and Ethnicity With COVID‐19 Outcomes in Rheumatic Disease: Data From the COVID‐19 Global Rheumatology Alliance Physician Registry